Work

Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma

Year: 2020

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2020.08.027

Authors: Shebli Atrash, Syed Abbas Ali, Saad Z. Usmani

Institutions: Levine Cancer Institute, Johns Hopkins University

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, Bristol-Myers Squibb, Sanofi, Leukemia and Lymphoma Society, Celgene, AbbVie, Array BioPharma, Takeda Pharmaceuticals U.S.A., Pharmacyclics, National Cancer Institute, Janssen Biotech, Janssen Pharmaceuticals

Award: G1598996110

OpenAlex ID: W3087350210

FWCI: 0.401

Cites: 159

Cited by: 7

Related to: 10